Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits


escrs app advert yo advert

Aniridia after blunt trauma and presumed wound dehiscence in a pseudophakic eye

Search Title by author or title

Session Details

Session Title: Presented Poster Session: Solutions for Traumatic Cases

Session Date/Time: Tuesday 13/09/2016 | 09:30-11:00

Paper Time: 10:00

Venue: Poster Village: Pod 3

First Author: : K.Kim SOUTH KOREA

Co Author(s): :    W. Kim              

Abstract Details


To report a pseudophakic patient who experienced isolated total aniridia without damage to other intraocular structures following blunt trauma to the eye.


Inje University Haeundae Paik Hospital


This patient had a history of uneventful cataract surgery using a small clear corneal incision (CCI). This 71-year-old male presented at our clinic with glare in his left eye. He reported that he had fallen down while drunk and struck his left eye against a stone on the road 15 days earlier. He had undergone cataract surgery on his left eye nine months before the accident at another eye clinic.


Slit-lamp examination showed total aniridia in his left eye, but there was no hyphema or cells in the anterior chamber. The intraocular lens in his left eye was stable, without decentration, dislocation, or zonular dehiscence and remained in an intact capsular bag. Review of the medical records from the surgical clinic at which he had undergone cataract surgery indicated no specific findings for any intraocular structure including the iris. He had previously undergone an uneventful phacoemulsification for his left eye through a 2.2 mm CCI, followed by the implantation of a single piece acrylic intraocular lens inside an intact capsular bag.


This report showed that small-sized CCIs can be opened postoperatively by trauma and that this can result in isolated total aniridia without damage to other intraocular structures.

Financial Disclosure:


Back to previous